Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    November 10, 2015November 12, 2015

    New Metastatic Melanoma Treatment from Caladrius Shows Promise

    News
    Caladrius Biosciences, Inc., recently presented novel data at the 2015 Annual Meeting of the Society for Immunotherapy of Cancer (SITC), which took place in Baltimore, Maryland, Nov. 4-8, 2015. The clinical and ... Read more
    November 5, 2015November 5, 2015

    IMLYGIC, an Unresectable Melanoma Treatment, Gets Positive CHMP Opinion

    News
    Amgen announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), has given a positive recommendation for IMLYGIC (talimogene laherparepvec) as a treatment for adult ... Read more
    November 5, 2015November 5, 2015

    La Roche-Posay Promotes ‘SOS-Save Our Skin’ Program for 5th Year

    News
    La Roche-Posay, a global leader in ultraviolet (UV) protection, is continuing its work to increase public awareness of  skin cancer and prevention with its SOS – Save our Skin Campaign, now in ... Read more
    October 22, 2015October 22, 2015

    For Treatment-Naive Melanoma Patients, Nivolumab May Hold Added Benefit

    News
    According to a recently released collection of papers (dossier) by the Institute for Quality and Efficiency in Health Care (IQWiG), use of the drug Nivolumab (trade name: Opdivo) may be ... Read more
    October 20, 2015October 22, 2015

    ‘Mole Mapper’ iPhone App to Aid Understanding of Melanomas in Research Study

    News
    Seattle, Washington-based, nonprofit biomedical research organization Sage Bionetworks, in collaboration with Oregon Health & Science University (OHSU) and National Cancer Institute cancer biologist Dan Webster, PhD, has  announced the launch of ... Read more
    October 15, 2015October 22, 2015

    Dr. Alberto Pappo Interviewed About Pediatric Melanoma

    News
    Estimates indicate that each year in the United States, there are about 400 new diagnosis of melanoma among those younger than 19 years of age. According to the St. Jude Children’s ... Read more
    October 13, 2015October 13, 2015

    Opdivo/ Yervoy Regimen Receives FDA Approval for BRAF V600 Wild-Type Unresectable or Metastatic Melanoma

    News
    Bristol-Myers Squibb Company announced it has received US Food and Drug Administration (FDA) approval for the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) in the treatment of patients diagnosed with BRAF V600 wild-type unresectable or metastatic melanoma ... Read more
    October 1, 2015October 13, 2015

    Arteries Are Better Than Veins for Liquid Biopsy, According to Study

    News
    Researchers from Thomas Jefferson Medical School (TJMS), Philadelphia, have recently released study findings which may hold important implications for a novel test currently approved for use to detect circulating tumor ... Read more
    September 24, 2015September 24, 2015

    NICE Approves Keytruda for Melanoma

    News
    Melanoma patients in England who have ceased responding to standard-of-care treatments can soon avail of a new immunotherapy drug that works by “unmasking” cancer cells and reprogramming the body’s immune system ... Read more
    September 22, 2015September 25, 2015

    Novel Discoveries May Hold Answers For Treatment-Resistant Melanoma

    News
    UCLA scientists have recently released study findings which may hold important implications in the field of metastatic melanoma research. The study entitled, “Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance“, ... Read more
    September 17, 2015September 17, 2015

    Immune Irregularities May Increase Melanoma Risk Among Certain Non-Hodgkin’s Lymphoma Survivors

    News
    A collaborative team of interdisciplinary researchers led by Clara J.K. Lam, MPH, a predoctoral fellow in the Radiation Epidemiology Branch of the National Cancer Institute (NCI) and PhD student in cancer ... Read more
    September 15, 2015September 15, 2015

    Adding Aspirin to Cancer Immunotherapy Slows Tumor Growth in Mice

    News
    A multidisciplinary team of researchers from the Francis Crick Institute, with funding from Cancer Research UK, have recently released results that could advance immunotherapy treatment options for certain cancers, such as ... Read more
    September 10, 2015September 15, 2015

    EMA Accepts Immunocore’s IMCgp100 for Adaptive Pathway Pilot Program In Melanoma

    News
    Immunocore Limited, one of the world’s leading biotechnology companies with a highly innovative immuno-oncology platform technology called ImmTACs, has just announced its lead product candidate, IMCgp100, has been accepted by the European Medicines ... Read more
    September 3, 2015September 3, 2015

    Researchers Identify Novel Mutation in Melanoma Cancer Cells

    News
    In a recent study published in Science Signaling entitled “The E3 ligase APC/CCdh1 promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth“, scientists from the Boston University School ... Read more
    September 1, 2015September 14, 2015

    SciBase US Reader Study for Nevisense Arrives at Positive Results, Improves Melanoma Diagnoses Accuracy

    News
    SciBase AB, a Swedish medical technology company headquartered in Stockholm, has recently announced the results of its US Reader Study. According to SciBase, the addition of Nevisense, which uses Electrical Impedance Spectroscopy ... Read more
    August 28, 2015August 28, 2015

    Not All Dermatology Treatments Are Necessary, According to The American Academy of Dermatology

    News
    The American Academy of Dermatology has recently updated its recommendations on a wide variety of dermatologic tests and treatments that may not be medically necessary. Costly tests are sometimes done on patients with ... Read more
    August 24, 2015August 25, 2015

    Radio Host and Research Center Founder Sharon Kleyne Reports on Dangers of Malignant Melanoma, Sun Exposure and Dehydration

    News
    With summers coming in earlier and lasting longer, and the sun’s UV rays growing all the more harsh in several parts of America, Sharon Kleyne, host of the Sharon Kleyne Hour Power ... Read more
    August 21, 2015August 21, 2015

    Having Fewer Moles Could Correlate To Worse Melanoma Diagnosis

    News
    When it comes to predicting risk for skin cancer, many of us, including physicians, believe having more than 50 moles puts one at a much higher risk of developing melanoma. ... Read more
    August 19, 2015August 19, 2015

    New Therapeutic Approach for Metastatic Melanoma Based on Pin1-FOXM1 Interaction

    News
    A study recently published in the journal Oncogene revealed a new therapeutic strategy for advanced metastatic melanoma based on the interaction between two particular factors – Pin1 and FOXM1. The ... Read more
    August 17, 2015August 17, 2015

    Study Shows Increased Melanoma Risk Among Transplant Recipients

    News
    A research team from Johns Hopkins Bloomberg School of Public Health found transplant recipients are more likely to develop aggressive forms of melanoma. The study entitled “Melanoma Risk and Survival Among ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.